Read more about the article Is Cancer Curable? | What does It mean To Be Treated For Cancer Instead Of Referring As Cured Of Cancer
In this blog post you can know almost everything about is cancer curable or not and its different treatments. Is Cancer Curable? | What does It mean To Be Treated For Cancer Instead Of Referring As Cured Of Cancer

Is Cancer Curable? | What does It mean To Be Treated For Cancer Instead Of Referring As Cured Of Cancer

Is Cancer Curable? It is the most common question of every cancer patient. Here you can consult with the best medical oncologist for cancer treatment in Delhi. A cure means…

Continue ReadingIs Cancer Curable? | What does It mean To Be Treated For Cancer Instead Of Referring As Cured Of Cancer
Read more about the article About Ependymoma Brain Tumor, Its Symptoms, Types And Treatments
About Ependymoma Brain Tumor, Its Symptoms, Types And Treatments

About Ependymoma Brain Tumor, Its Symptoms, Types And Treatments

Introduction To Childhood Ependymoma Childhood ependymoma is a disease in which malignant cells form in the tissues of the brain and spinal cord. These tumors can occur anywhere within the…

Continue ReadingAbout Ependymoma Brain Tumor, Its Symptoms, Types And Treatments
Read more about the article Immunotherapy in Triple Negative Breast Cancer (TNBC)
Immunotherapy in Triple Negative Breast Cancer (TNBC)

Immunotherapy in Triple Negative Breast Cancer (TNBC)

Immunotherapy in Triple-Negative Breast Cancer (TNBC) Is implemented. It accounts for about 13% of breast cancer cases and is named because it tests negative for estrogen and progesterone receptors and…

Continue ReadingImmunotherapy in Triple Negative Breast Cancer (TNBC)
Read more about the article Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC):
Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC):

Chimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC):

Chimeric Antigen Receptor (CAR)-T-Cell Therapy exert an immune response against non-small-cell lung cancer (NSCLC). As novel agents of immunotherapy, CAR-T cells target specific antigens in NSCLC.  Let us summarize the common…

Continue ReadingChimeric antigen receptor (CAR)-T-cell therapy in non-small-cell lung cancer (NSCLC):
Read more about the article Immunotherapy and COVID risk
The Immunotherapy and COVID risk is prevalent. Throughout the outbreak, the immunotherapy community was uniquely challenged by circumstances. Immunotherapy and COVID risk

Immunotherapy and COVID risk

Practically every aspect of modern life now is up and down by the ongoing COVID-19 pandemic. Substantial disruptions to the day-to-day practices of caring for patients in merely a year time period…

Continue ReadingImmunotherapy and COVID risk
Read more about the article Immune system modulator in prostate cancer
Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer among men. PCa is usually diagnosed in men above 65 years of age. Immune system modulator in prostate cancer

Immune system modulator in prostate cancer

Prostate cancer (PCa) is the most commonly diagnosed non-cutaneous cancer among men. PCa is usually diagnosed in men above 65 years of age.  There are various treatment options for prostate…

Continue ReadingImmune system modulator in prostate cancer